CD19+ ACUTE LEUKEMIA
Clinical trials for CD19+ ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CD19+ ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for CD19+ ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Patient's own immune cells be trained to cure leukemia?
⭐️ CURE ⭐️ OngoingThis trial tests a personalized therapy where a patient's own T cells are collected, genetically modified to recognize and attack CD19-positive leukemia cells, and then infused back into the patient. It is designed for children and young adults with relapsed or refractory CD19+ a…
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Seattle Children's Hospital • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
New hope for leukemia patients: drug cocktail shows promise
Disease control ENROLLING_BY_INVITATIONThis phase II trial is testing whether adding the drug asciminib to standard treatment can improve outcomes for people newly diagnosed with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). The study will enroll 55 participants and involves several phases o…
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New infusion strategy aims to keep CAR t cells fighting leukemia longer
Disease control OngoingThis pilot study tests whether giving special immune cells called T-APCs after CAR T cell therapy can help the CAR T cells persist longer in the body and prevent leukemia from returning. It involves 30 children and young adults with relapsed or refractory CD19+ leukemia who have …
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC